<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03353727</url>
  </required_header>
  <id_info>
    <org_study_id>JGS_2016_25</org_study_id>
    <nct_id>NCT03353727</nct_id>
  </id_info>
  <brief_title>Orthoptic Rehabilitation for Low Vision People With Innovative Mechanisms (Eye Tracker and Tactile Device)</brief_title>
  <acronym>VISIONUM</acronym>
  <official_title>Orthoptic Rehabilitation for Low Vision People With Innovative Mechanisms (Eye Tracker and Tactile Device)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project is working on orthoptic rehabilitation for low vision people. The aim of the
      project is to assess the interest and integration of this rehabilitation device used at home,
      in low-vision private practice and at the hospital. It leads to develop and evaluate an
      innovative device to integrate and adjust monitoring of patients according to their need and
      their progress, to create new interactions with the patient, enabling the orthoptist to stay
      in touch with his patient at home between rehabilitation sessions and to obtain a more fine
      and objective analysis of the exercises done by the patient.

      Using an eye tracker and a digital tactile screen with data uploads allows the practitioner
      to observe the progress objectively. It also leads the patient to a better understanding of
      his/her visual behavior and of the effects of rehabilitation. Therefore, it will be easier to
      adopt better strategies.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    lack of Financial support
  </why_stopped>
  <start_date type="Actual">June 20, 2017</start_date>
  <completion_date type="Actual">December 20, 2018</completion_date>
  <primary_completion_date type="Actual">December 20, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>score assessing the feasibility of the rehabilitation</measure>
    <time_frame>18 months after inclusion</time_frame>
    <description>System Usability Scale score</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Low Vision</condition>
  <arm_group>
    <arm_group_label>Orthoptic rehabilitation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Orthoptic rehabilitation</intervention_name>
    <description>Orthoptic rehabilitation using innovative mechanisms (eye tracker and tactile device) for low vision people</description>
    <arm_group_label>Orthoptic rehabilitation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients suffering from visual impairment, with a need for visual rehabilitation

          -  Visual acuity (≤1.3 logMAR)

          -  Good knowledge of French language

          -  Informed consent of research

        Exclusion Criteria:

          -  Medical treatment that may interfere with the study

          -  Degenerative diseases or any other diseases that may interfere with the study.

          -  Mini-Mental State Examination Score without visual item ≤ 20/25

          -  Pregnancy and lactation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-François Girmens, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier National d'Ophtalmologie des Quinze Vingts, Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fondation Hospitalière Sainte Marie</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fondation Ophtalmologique Adolphe de Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <study_first_submitted>October 25, 2017</study_first_submitted>
  <study_first_submitted_qc>November 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 27, 2017</study_first_posted>
  <last_update_submitted>February 18, 2019</last_update_submitted>
  <last_update_submitted_qc>February 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Orthoptic rehabilitation</keyword>
  <keyword>low vision</keyword>
  <keyword>eye tracker</keyword>
  <keyword>tactile device</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vision, Low</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

